Supplementary Figure 7: G-CSF treatment does not alter the glycomic profile of healthy human neutrophils.
From: JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia
MALDI-TOF mass spectrometry of permethylated N-glycans from (a) an unrelated healthy donor and (b) an unrelated healthy donor treated additionally with G-CSF. Other conditions are identical to those in Supplementary Figure 6. G-CSF treatment does not alter the composition or the relative abundance of the mature N-glycans found in the lower panels of the spectra.
